DexCom to Present at 33rd Annual J.P. Morgan Healthcare Conference
January 07 2015 - 8:30AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer,
Chief Executive Officer, will present an update on the company at
the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco,
California on Tuesday, January 13, 2015 at 3:30pm (PST). The
presentation, which will occur live at the Westin St. Francis
Hotel, will be concurrently webcast.
The link to the webcast will be available on the DexCom website
at www.dexcom.com by navigating to “Our Company,” then “Investor
Relations,” and then “Events and Webcasts” and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is
developing and marketing continuous glucose monitoring systems for
ambulatory use by patients and by healthcare providers in the
hospital.
Cautionary Statement Regarding Forward Looking
Statements
DexCom is a medical device company with a limited operating
history. Successful commercialization of the company's products is
subject to numerous risks and uncertainties, including a lack of
acceptance in the marketplace by physicians and patients, the
inability to manufacture products in commercial quantities at an
acceptable cost, possible delays in the company's development
programs, the inability of patients to receive reimbursement from
third-party payors and inadequate financial and other resources.
Certain of these risks and uncertainties, in addition to other
risks, are more fully described in the company's quarterly report
on Form 10-Q for the quarter ended September 30, 2014, as filed
with the Securities and Exchange Commission on November 6,
2014.
DexCom, Inc.Steven R. PacelliExecutive Vice President,
Strategy and Corporate Development858-200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2023 to Apr 2024